(0.14%) 5 529.50 points
(0.19%) 39 545 points
(0.07%) 19 942 points
(0.28%) $81.77
(-1.31%) $2.57
(-0.02%) $2 339.20
(-0.27%) $29.48
(-0.63%) $995.60
(-0.36%) $0.930
(-0.39%) $10.63
(-0.18%) $0.789
(1.91%) $87.36
0.00% $ 14.69
Live Chart Being Loaded With Signals
Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products...
Stats | |
---|---|
Volumen de hoy | 107 |
Volumen promedio | 33 |
Capitalización de mercado | 3.09B |
EPS | $62.80 ( Q4 | 2024-03-31 ) |
Próxima fecha de ganancias | ( $0 ) 2024-07-31 |
Last Dividend | $0.185 ( 2021-09-28 ) |
Next Dividend | $0 ( N/A ) |
P/E |
11.75 (Sector) 0 (Industry) 0 |
ATR14 | $0 (0.00%) |
MediPal Holdings Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
MediPal Holdings Finanzas
Annual | 2024 |
Ingresos: | $3 558.73B |
Beneficio Bruto: | $233.01B (6.55 %) |
EPS: | $195.84 |
FY | 2024 |
Ingresos: | $3 558.73B |
Beneficio Bruto: | $233.01B (6.55 %) |
EPS: | $195.84 |
FY | 2023 |
Ingresos: | $3 360.01B |
Beneficio Bruto: | $212.12B (6.31 %) |
EPS: | $184.82 |
FY | 2022 |
Ingresos: | $3 290.92B |
Beneficio Bruto: | $205.11B (6.23 %) |
EPS: | $140.13 |
Financial Reports:
No articles found.
MediPal Holdings Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.191 | 2021-03-29 |
Last Dividend | $0.185 | 2021-09-28 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 2 | -- |
Total Paid Out | $0.376 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.85 | -- |
Div. Sustainability Score | 4.45 | |
Div.Growth Potential Score | 1.119 | |
Div. Directional Score | 2.78 | -- |
Year | Amount | Yield |
---|
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Ex Date | Amount | Declaration Date | Record Date | Payment Date |
---|---|---|---|---|
28 Sep 2021 | $0.185 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
29 Mar 2021 | $0.191 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
NACB | Ex Dividend Junior | 2023-08-15 | Quarterly | 0 | 0.00% | |
ASXFY | Ex Dividend Knight | 2023-09-07 | Semi-Annually | 0 | 0.00% | |
IDCBY | Ex Dividend Knight | 2023-07-06 | Annually | 0 | 0.00% | |
TXHPF | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
EMSHF | Ex Dividend Knight | 2023-08-15 | Annually | 0 | 0.00% | |
PNBI | Ex Dividend Knight | 2023-09-14 | Quarterly | 0 | 0.00% | |
CEFC | Ex Dividend Knight | 2023-09-14 | Quarterly | 0 | 0.00% | |
KTHN | Ex Dividend Knight | 2023-09-14 | Quarterly | 0 | 0.00% | |
AAVMY | Ex Dividend Knight | 2023-08-18 | Semi-Annually | 0 | 0.00% | |
YAHOF | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0117 | 1.500 | 9.77 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0231 | 1.200 | 9.23 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0708 | 1.500 | -0.325 | -0.487 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.235 | 0.800 | 8.83 | 7.06 | [1 - 3] |
quickRatioTTM | 1.047 | 0.800 | 8.55 | 6.84 | [0.8 - 2.5] |
cashRatioTTM | 0.228 | 1.500 | 9.84 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 6 442.12 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 0 | 2.00 | 0 | 0 | [0 - 30] |
freeCashFlowPerShareTTM | 0 | 2.00 | 0 | 0 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.0655 | 1.000 | -2.24 | -2.24 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0145 | 1.000 | -1.710 | -1.710 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 1.978 | 0.800 | 0.146 | 0.117 | [0.5 - 2] |
Total Score | 4.45 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 11.98 | 1.000 | 8.89 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0708 | 2.50 | -0.209 | -0.487 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0 | 2.00 | 0 | 0 | [0 - 30] |
dividendYielPercentageTTM | 0.0151 | 1.500 | 9.62 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0 | 2.00 | 0 | 0 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.0323 | 1.500 | -3.12 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0 | 1.000 | -2.50 | 0 | [0.1 - 0.5] |
Total Score | 1.119 |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
MediPal Holdings
Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is also involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; animal health products for companion animals; food processing raw materials for agriculture, fisheries, and livestock; and livestock feed additives, seasonings, veterinary medical equipment, packaging materials, industrial chemicals, and other products. In addition, it engages in the contract-based epidemiological studies, clinical studies, etc.; creation of a computerized medical supply database and master product databases for medical facilities; health insurance claims reviews, medical coding dispatch, outsourcing, and remote education activities; life and non-life insurance agency business; cleaning management; management and operation of distribution centers; commissioned delivery and worker dispatch business; and planning, management, administration, and product and service development for the class A health dispensing pharmacies service brand. Medipal Holdings Corporation serves hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company was formerly known as Mediceo Paltac Holdings Co., Ltd. and changed its name to Medipal Holdings Corporation in October 2009. Medipal Holdings Corporation was founded in 1898 and is headquartered in Tokyo, Japan.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico